BOSTON SCIENTIFIC CORP (BSX.DE) Stock Fundamental Analysis
Europe • Frankfurt Stock Exchange • FRA:BSX • US1011371077
78 EUR
-0.8 (-1.02%)
Last: Jan 30, 2026, 07:00 PM
Taking everything into account, BSX scores 6 out of 10 in our fundamental rating. BSX was compared to 63 industry peers in the Health Care Equipment & Supplies industry. While BSX belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. BSX is valued quite expensively, but it does show have an excellent growth rating. These ratings could make BSX a good candidate for growth investing.
1. Profitability
1.1 Basic Checks
- BSX had positive earnings in the past year.
- BSX had a positive operating cash flow in the past year.
- BSX had positive earnings in 4 of the past 5 years.
- In the past 5 years BSX always reported a positive cash flow from operatings.
1.2 Ratios
- With a decent Return On Assets value of 6.54%, BSX is doing good in the industry, outperforming 74.60% of the companies in the same industry.
- The Return On Equity of BSX (11.93%) is better than 73.02% of its industry peers.
- The Return On Invested Capital of BSX (8.09%) is better than 69.84% of its industry peers.
- BSX had an Average Return On Invested Capital over the past 3 years of 6.59%. This is below the industry average of 9.95%.
- The 3 year average ROIC (6.59%) for BSX is below the current ROIC(8.09%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.54% | ||
| ROE | 11.93% | ||
| ROIC | 8.09% |
ROA(3y)3.72%
ROA(5y)2.77%
ROE(3y)6.77%
ROE(5y)5.1%
ROIC(3y)6.59%
ROIC(5y)5.7%
1.3 Margins
- The Profit Margin of BSX (14.42%) is better than 84.13% of its industry peers.
- BSX's Profit Margin has declined in the last couple of years.
- BSX has a better Operating Margin (19.40%) than 82.54% of its industry peers.
- BSX's Operating Margin has been stable in the last couple of years.
- BSX's Gross Margin of 68.57% is fine compared to the rest of the industry. BSX outperforms 77.78% of its industry peers.
- BSX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.4% | ||
| PM (TTM) | 14.42% | ||
| GM | 68.57% |
OM growth 3Y0.91%
OM growth 5Y1.48%
PM growth 3Y10.12%
PM growth 5Y-24.05%
GM growth 3Y-0.15%
GM growth 5Y-0.56%
2. Health
2.1 Basic Checks
- BSX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- The number of shares outstanding for BSX has been increased compared to 1 year ago.
- The number of shares outstanding for BSX has been increased compared to 5 years ago.
- The debt/assets ratio for BSX is higher compared to a year ago.
2.2 Solvency
- BSX has an Altman-Z score of 5.25. This indicates that BSX is financially healthy and has little risk of bankruptcy at the moment.
- BSX has a Altman-Z score of 5.25. This is amongst the best in the industry. BSX outperforms 85.71% of its industry peers.
- The Debt to FCF ratio of BSX is 3.03, which is a good value as it means it would take BSX, 3.03 years of fcf income to pay off all of its debts.
- BSX has a better Debt to FCF ratio (3.03) than 73.02% of its industry peers.
- BSX has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
- With a Debt to Equity ratio value of 0.48, BSX perfoms like the industry average, outperforming 49.21% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.48 | ||
| Debt/FCF | 3.03 | ||
| Altman-Z | 5.25 |
ROIC/WACC0.83
WACC9.79%
2.3 Liquidity
- BSX has a Current Ratio of 1.51. This is a normal value and indicates that BSX is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 1.51, BSX is in line with its industry, outperforming 47.62% of the companies in the same industry.
- BSX has a Quick Ratio of 1.51. This is a bad value and indicates that BSX is not financially healthy enough and could expect problems in meeting its short term obligations.
- With a Quick ratio value of 0.96, BSX perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.51 | ||
| Quick Ratio | 0.96 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 25.00% over the past year.
- BSX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.56% yearly.
- Looking at the last year, BSX shows a very strong growth in Revenue. The Revenue has grown by 21.62%.
- The Revenue has been growing by 9.30% on average over the past years. This is quite good.
EPS 1Y (TTM)25%
EPS 3Y15.48%
EPS 5Y9.56%
EPS Q2Q%19.05%
Revenue 1Y (TTM)21.62%
Revenue growth 3Y12.1%
Revenue growth 5Y9.3%
Sales Q2Q%20.34%
3.2 Future
- Based on estimates for the next years, BSX will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.06% on average per year.
- BSX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.60% yearly.
EPS Next Y22.12%
EPS Next 2Y18.13%
EPS Next 3Y16.37%
EPS Next 5Y15.06%
Revenue Next Year20.92%
Revenue Next 2Y16.08%
Revenue Next 3Y14.31%
Revenue Next 5Y12.6%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 31.71, which means the current valuation is very expensive for BSX.
- BSX's Price/Earnings ratio is in line with the industry average.
- When comparing the Price/Earnings ratio of BSX to the average of the S&P500 Index (28.30), we can say BSX is valued inline with the index average.
- With a Price/Forward Earnings ratio of 26.65, BSX can be considered very expensive at the moment.
- The rest of the industry has a similar Price/Forward Earnings ratio as BSX.
- When comparing the Price/Forward Earnings ratio of BSX to the average of the S&P500 Index (25.57), we can say BSX is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.71 | ||
| Fwd PE | 26.65 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, BSX is valued a bit more expensive than the industry average as 61.90% of the companies are valued more cheaply.
- BSX's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 36.2 | ||
| EV/EBITDA | 28.92 |
4.3 Compensation for Growth
- BSX's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- BSX has a very decent profitability rating, which may justify a higher PE ratio.
- A more expensive valuation may be justified as BSX's earnings are expected to grow with 16.37% in the coming years.
PEG (NY)1.43
PEG (5Y)3.32
EPS Next 2Y18.13%
EPS Next 3Y16.37%
5. Dividend
5.1 Amount
- BSX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
BOSTON SCIENTIFIC CORP / BSX.DE FAQ
What is the ChartMill fundamental rating of BOSTON SCIENTIFIC CORP (BSX.DE) stock?
ChartMill assigns a fundamental rating of 6 / 10 to BSX.DE.
What is the valuation status for BSX stock?
ChartMill assigns a valuation rating of 3 / 10 to BOSTON SCIENTIFIC CORP (BSX.DE). This can be considered as Overvalued.
How profitable is BOSTON SCIENTIFIC CORP (BSX.DE) stock?
BOSTON SCIENTIFIC CORP (BSX.DE) has a profitability rating of 7 / 10.
What is the valuation of BOSTON SCIENTIFIC CORP based on its PE and PB ratios?
The Price/Earnings (PE) ratio for BOSTON SCIENTIFIC CORP (BSX.DE) is 31.71 and the Price/Book (PB) ratio is 5.92.
Can you provide the expected EPS growth for BSX stock?
The Earnings per Share (EPS) of BOSTON SCIENTIFIC CORP (BSX.DE) is expected to grow by 22.12% in the next year.